Normal function · from ai-gene-review (P12830, commit 79fe13b38970) · AI-generated, not KB evidence

CDH1 encodes E-cadherin (epithelial cadherin), the prototypical type-I classical cadherin and the principal calcium-dependent cell-cell adhesion molecule of epithelia. This single-pass transmembrane glycoprotein has five extracellular cadherin (EC) repeats that bind calcium and mediate homophilic trans-adhesion with E-cadherin on neighbouring cells, while its cytoplasmic tail nucleates the cadherin-catenin complex by binding p120-catenin, beta-catenin and gamma-catenin/plakoglobin; alpha-catenin in turn couples this complex to the cortical actin cytoskeleton. Through these interactions E-cadherin builds and maintains adherens junctions, establishes epithelial apicobasal polarity and tissue integrity, and facilitates early desmosome assembly. E-cadherin is a potent invasion and tumour suppressor: loss of function promotes epithelial-to-mesenchymal transition and is causative in hereditary diffuse gastric cancer and lobular breast carcinoma. E-cadherin is additionally exploited as a host cell-surface receptor by Listeria monocytogenes internalin A.

E-cadherin engages in calcium-dependent homophilic trans-interaction with E-cadherin molecules on adjacent epithelial cells through its five extracellular cadherin (EC) repeats. This homophilic binding is the molecular basis of E-cadherin-mediated cell-cell adhesion and the nucleation of adherens junctions.
molecular function: cadherin binding · directly involved in: homophilic cell-cell adhesion · locations: lateral plasma membrane; adherens junction
The C-terminal cytoplasmic domain of E-cadherin binds beta-catenin (and gamma-catenin/plakoglobin), forming the cadherin-catenin complex. This complex couples E-cadherin to the cortical actin cytoskeleton via alpha-catenin, mechanically linking cell-cell adhesion to the cytoskeleton and stabilizing adherens junctions.
molecular function: beta-catenin binding · directly involved in: adherens junction organization · locations: lateral plasma membrane; adherens junction
The juxtamembrane domain of E-cadherin's cytoplasmic tail binds p120-catenin (CTNND1/delta-catenin) at a site distinct from the C-terminal beta-catenin-binding domain. p120-catenin binding masks a dileucine endocytic motif and stabilizes E-cadherin at the plasma membrane, thereby controlling cadherin surface levels, turnover, and adhesion strength.
molecular function: delta-catenin binding · directly involved in: adherens junction organization · locations: lateral plasma membrane; adherens junction
Calcium ions bind at the linker regions between E-cadherin's extracellular cadherin repeats, rigidifying the ectodomain into the conformation required for homophilic trans-adhesion; cadherin-mediated cell-cell adhesion is strictly calcium-dependent.
molecular function: calcium ion binding · directly involved in: homophilic cell-cell adhesion · locations: lateral plasma membrane
In the knowledge base · computed from kb/ at build time

Disorders

Relationship is the entry's genetic[].relationship_type. untyped means the entry has a genetic record for the gene but does not type it; its free-text association is shown instead.

DisorderRelationshipWhere the gene appears
CDH1-Related Hereditary Diffuse Gastric Cancer causative germline loss of function
mechanism: Germline CDH1 First-Hit Inactivation
Gastric Adenocarcinoma causative germline
mechanism: CDH1 Inactivation and E-cadherin Loss
subtype: Diffuse; HDGC
scoped to subtype: HDGC
Gastric Cancer H. pylori Associated untyped
Somatic and Germline Mutations
mechanism: CDH1/E-cadherin Inactivation
Ulcerative Colitis untyped
Risk Factor
mechanism: Epithelial Barrier Dysfunction
Arthrogryposis-Renal Dysfunction-Cholestasis Syndrome no genetic record
mechanism: Loss of Apical-Basolateral Epithelial Polarity
ClinGen gene–disease validity · snapshot 2026-10-03 · matched to entries by MONDO

An entry matches when ClinGen's MONDO disease is the entry's own disease term, a subtype term, or an exact-match mapping. An amber status marks an entry ClinGen supports the gene for (Definitive, Strong or Moderate) whose own record does not type it. A Limited, Disputed or Refuted tier on such an entry is not a gap.

ClinGen diseaseMOIClassificationdismech entry
CDH1-related diffuse gastric and lobular breast cancer syndrome MONDO:0100488 AD Definitive
2024-03-22
Mechanism modules · computed from kb/

Identity from HGNC (snapshot 2026-10-01). Page layers are described in the gene pages documentation.